Non-incidental coamplification of Myc and ERBB2, and Myc and EGFR, in gastric adenocarcinomas
- 1 June 2007
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 20 (6), 622-631
- https://doi.org/10.1038/modpathol.3800777
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Manifestation, mechanisms and mysteries of gene amplificationsCancer Letters, 2006
- Amplification of genes encoding KIT, PDGFRα and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiformeThe Journal of Pathology, 2005
- Murine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene lociOncogene, 2003
- Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocationsBlood, 2003
- Status of c‐erbB‐2 in gastric adenocarcinoma: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme‐linked immuno‐sorbent assayInternational Journal of Cancer, 2002
- In Vivo Amplification of the PAX3-FKHR and PAX7-FKHR Fusion Genes in Alveolar RhabdomyosarcomaHuman Molecular Genetics, 1996
- Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancerCancer Genetics and Cytogenetics, 1995
- myc FUNCTION AND REGULATIONAnnual Review of Biochemistry, 1992
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986
- Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell lineNature, 1983